Published in Biomaterials on February 24, 2010
SDF-1 promotes endochondral bone repair during fracture healing at the traumatic brain injury condition. PLoS One (2013) 1.47
Harnessing and modulating inflammation in strategies for bone regeneration. Tissue Eng Part B Rev (2011) 1.37
Extracellular vesicles: potential roles in regenerative medicine. Front Immunol (2014) 1.17
Permanent protection of PLG scaffold transplanted allogeneic islet grafts in diabetic mice treated with ECDI-fixed donor splenocyte infusions. Biomaterials (2011) 1.00
Real time monitoring of biomaterial-mediated inflammatory responses via macrophage-targeting NIR nanoprobes. Biomaterials (2011) 0.98
Paracrine molecules of mesenchymal stem cells for hematopoietic stem cell niche. Bone Marrow Res (2011) 0.96
The promotion of mandibular defect healing by the targeting of S1P receptors and the recruitment of alternatively activated macrophages. Biomaterials (2013) 0.96
Pro-angiogenic and anti-inflammatory regulation by functional peptides loaded in polymeric implants for soft tissue regeneration. Tissue Eng Part A (2012) 0.93
Biomaterial implants mediate autologous stem cell recruitment in mice. Acta Biomater (2011) 0.93
Fibroblast/fibrocyte: surface interaction dictates tissue reactions to micropillar implants. Biomacromolecules (2011) 0.91
The pivotal role of fibrocytes and mast cells in mediating fibrotic reactions to biomaterials. Biomaterials (2011) 0.89
In situ tissue regeneration through host stem cell recruitment. Exp Mol Med (2013) 0.87
In situ tissue regeneration: chemoattractants for endogenous stem cell recruitment. Tissue Eng Part B Rev (2013) 0.87
Human progenitor cell recruitment via SDF-1α coacervate-laden PGS vascular grafts. Biomaterials (2013) 0.86
Modulation of leukocyte infiltration and phenotype in microporous tissue engineering scaffolds via vector induced IL-10 expression. Biomaterials (2013) 0.86
Real-time detection of implant-associated neutrophil responses using a formyl peptide receptor-targeting NIR nanoprobe. Int J Nanomedicine (2012) 0.84
Tissue engineering bone using autologous progenitor cells in the peritoneum. PLoS One (2014) 0.82
The effect of erythropoietin on autologous stem cell-mediated bone regeneration. Biomaterials (2013) 0.82
The use of chemokine-releasing tissue engineering scaffolds in a model of inflammatory response-mediated melanoma cancer metastasis. Biomaterials (2011) 0.81
Fabrication of biocompatible, vibrational magnetoelastic materials for controlling cellular adhesion. Biosensors (Basel) (2012) 0.81
The effect of delivering the chemokine SDF-1α in a matrix-bound manner on myogenesis. Biomaterials (2014) 0.81
Alternative strategies to manipulate fibrocyte involvement in the fibrotic tissue response: pharmacokinetic inhibition and the feasibility of directed-adipogenic differentiation. Acta Biomater (2014) 0.80
Engineering the hematopoietic stem cell niche: Frontiers in biomaterial science. Biotechnol J (2015) 0.80
In vivo bioresponses to silk proteins. Biomaterials (2015) 0.79
Student Award for Outstanding Research Winner in the Ph.D. Category for the 9th World Biomaterials Congress, Chengdu, China, June 1-5, 2012: The interplay of bone-like extracellular matrix and TNF-α signaling on in vitro osteogenic differentiation of mesenchymal stem cells. J Biomed Mater Res A (2012) 0.79
Nano-Therapeutics for the Lung: State-of-the-Art and Future Perspectives. Curr Pharm Des (2015) 0.79
Effect of pore structure of macroporous poly(lactide-co-glycolide) scaffolds on the in vivo enrichment of dendritic cells. ACS Appl Mater Interfaces (2014) 0.78
In situ re-endothelialization via multifunctional nanoscaffolds. ACS Nano (2014) 0.78
The Impact of Mesenchymal Stem Cells on Differentiation of Hematopoietic Stem Cells. Adv Pharm Bull (2015) 0.78
Intraocular pressure changes: an important determinant of the biocompatibility of intravitreous implants. PLoS One (2011) 0.77
Leukocyte transmigration into tissue-engineered constructs is influenced by endothelial cells through Toll-like receptor signaling. Stem Cell Res Ther (2014) 0.77
Effects of nanoporous alumina on inflammatory cell response. J Biomed Mater Res A (2013) 0.77
Local delivery of VEGF and SDF enhances endothelial progenitor cell recruitment and resultant recovery from ischemia. Tissue Eng Part A (2015) 0.77
Reduction of inflammatory responses and enhancement of extracellular matrix formation by vanillin-incorporated poly(lactic-co-glycolic acid) scaffolds. Tissue Eng Part A (2012) 0.77
Chitosan-coated poly(lactic-co-glycolic) acid nanoparticles as an efficient delivery system for Newcastle disease virus DNA vaccine. Int J Nanomedicine (2014) 0.77
Winner of the Young Investigator Award of the Society for Biomaterials at the 10th World Biomaterials Congress, May 17-22, 2016, Montreal QC, Canada: Microribbon-based hydrogels accelerate stem cell-based bone regeneration in a mouse critical-size cranial defect model. J Biomed Mater Res A (2016) 0.77
Biomaterial-mediated modification of the local inflammatory environment. Front Bioeng Biotechnol (2015) 0.76
Enhanced Antiproliferative Effect of Carboplatin in Cervical Cancer Cells Utilizing Folate-Grafted Polymeric Nanoparticles. Nanoscale Res Lett (2015) 0.76
Tunable Controlled Release of Bioactive SDF-1α via Protein Specific Interactions within Fibrin/Nanoparticle Composites. J Mater Chem B Mater Biol Med (2015) 0.76
Stromal cell-derived factor-1 stimulates cell recruitment, vascularization and osteogenic differentiation. Tissue Eng Part A (2013) 0.76
Macrophage interactions with polylactic acid and chitosan scaffolds lead to improved recruitment of human mesenchymal stem/stromal cells: a comprehensive study with different immune cells. J R Soc Interface (2016) 0.75
Design, fabrication, and implementation of a wireless, passive implantable pressure sensor based on magnetic higher-order harmonic fields. Biosensors (Basel) (2011) 0.75
The Quest for Anti-inflammatory and Anti-infective Biomaterials in Clinical Translation. Front Bioeng Biotechnol (2016) 0.75
Neuropeptide Substance-P-Conjugated Chitosan Nanofibers as an Active Modulator of Stem Cell Recruiting. Int J Mol Sci (2016) 0.75
CD133 antibody conjugation to decellularized human heart valves intended for circulating cell capture. Biomed Mater (2015) 0.75
Micro- and Macrostructured PLGA/Gelatin Scaffolds Promote Early Cardiogenic Commitment of Human Mesenchymal Stem Cells In Vitro. Stem Cells Int (2016) 0.75
CXCL12/stromal-cell-derived factor-1 effectively replaces endothelial progenitor cells to induce vascularized ectopic bone. Stem Cells Dev (2014) 0.75
Specific Recruitment of Circulating Angiogenic Cells Using Biomaterials as Filters. Acta Biomater (2017) 0.75
Effects of Mesenchymal Stem Cell Derivatives on Hematopoiesis and Hematopoietic Stem Cells. Adv Pharm Bull (2017) 0.75
Delivery of stromal cell-derived factor 1α for in situ tissue regeneration. J Biol Eng (2017) 0.75
Cellular and molecular mechanisms of fibrosis. J Pathol (2008) 14.01
VEGF-induced adult neovascularization: recruitment, retention, and role of accessory cells. Cell (2006) 9.32
Redefining endothelial progenitor cells via clonal analysis and hematopoietic stem/progenitor cell principals. Blood (2006) 8.56
Foreign body reaction to biomaterials. Semin Immunol (2007) 8.32
Paracrine factors of mesenchymal stem cells recruit macrophages and endothelial lineage cells and enhance wound healing. PLoS One (2008) 5.91
Proinflammatory cytokines. Chest (2000) 5.89
Cytokine-mediated deployment of SDF-1 induces revascularization through recruitment of CXCR4+ hemangiocytes. Nat Med (2006) 5.22
Stromal cell-derived factor-1alpha plays a critical role in stem cell recruitment to the heart after myocardial infarction but is not sufficient to induce homing in the absence of injury. Circulation (2004) 4.79
Review: mesenchymal stem cells: cell-based reconstructive therapy in orthopedics. Tissue Eng (2005) 3.18
Plasma elevation of stromal cell-derived factor-1 induces mobilization of mature and immature hematopoietic progenitor and stem cells. Blood (2001) 3.01
SSEA-4 identifies mesenchymal stem cells from bone marrow. Blood (2006) 2.83
Engineering principles of clinical cell-based tissue engineering. J Bone Joint Surg Am (2004) 2.79
Engineering complex tissues. Tissue Eng (2006) 2.53
Bone marrow mesenchymal stem cells express a restricted set of functionally active chemokine receptors capable of promoting migration to pancreatic islets. Blood (2005) 2.39
Immunomodulatory function of bone marrow-derived mesenchymal stem cells in experimental autoimmune type 1 diabetes. J Immunol (2009) 2.15
Mast cells mediate acute inflammatory responses to implanted biomaterials. Proc Natl Acad Sci U S A (1998) 2.02
Modulation of the inflammatory response for enhanced bone tissue regeneration. Tissue Eng Part B Rev (2008) 1.92
Angiogenesis in tissue engineering: breathing life into constructed tissue substitutes. Tissue Eng (2006) 1.86
Distinct roles for the alpha and beta subunits in the functions of integrin alphaMbeta2. J Biol Chem (2004) 1.79
Angiogenic effects of sequential release of VEGF-A165 and PDGF-BB with alginate hydrogels after myocardial infarction. Cardiovasc Res (2007) 1.77
Controlled release of stromal cell-derived factor-1 alpha in situ increases c-kit+ cell homing to the infarcted heart. Tissue Eng (2007) 1.56
Fraktalkine produced by airway smooth muscle cells contributes to mast cell recruitment in asthma. J Immunol (2006) 1.49
Surface chemistry influences implant biocompatibility. Curr Top Med Chem (2008) 1.44
Platelet-derived stromal cell-derived factor-1 regulates adhesion and promotes differentiation of human CD34+ cells to endothelial progenitor cells. Circulation (2007) 1.39
Enhanced angiogenesis through controlled release of basic fibroblast growth factor from peptide amphiphile for tissue regeneration. Biomaterials (2006) 1.21
Method to analyze three-dimensional cell distribution and infiltration in degradable scaffolds. Tissue Eng Part C Methods (2008) 1.21
Locally enhanced angiogenesis promotes transplanted cell survival. Tissue Eng (2004) 1.10
The effect of anisotropic architecture on cell and tissue infiltration into tissue engineering scaffolds. Biomaterials (2006) 1.09
Transforming growth factor-beta1 modulates extracellular matrix production, proliferation, and apoptosis of endothelial progenitor cells in tissue-engineering scaffolds. Circulation (2006) 1.06
New indications for treatment of chronic inflammation by TNF-alpha blockade. Am J Med Sci (2003) 1.00
Improved autograft survival of mesenchymal stromal cells by plasminogen activator inhibitor 1 inhibition. Stem Cells (2009) 1.00
Novel polymeric scaffolds using protein microbubbles as porogen and growth factor carriers. Tissue Eng Part C Methods (2010) 0.96
Extrinsic and intrinsic pathways of apoptosis in aseptic loosening after total hip replacement. Biomaterials (2008) 0.96
Human mast cells transmigrate through human umbilical vein endothelial monolayers and selectively produce IL-8 in response to stromal cell-derived factor-1 alpha. J Immunol (2000) 0.95
H4 histamine receptor mediates optimal migration of mast cell precursors to CXCL12. J Allergy Clin Immunol (2007) 0.95
Effects of biomaterial-induced inflammation on fibrosis and rejection. Semin Immunol (2008) 0.94
TRPM4 regulates migration of mast cells in mice. Cell Calcium (2008) 0.93
Species and density of implant surface chemistry affect the extent of foreign body reactions. Langmuir (2008) 0.90
The recruitment of primitive Lin(-) Sca-1(+), CD34(+), c-kit(+) and CD271(+) cells during the early intraperitoneal foreign body reaction. Biomaterials (2007) 0.88
Mice lacking beta6 integrin in skin show accelerated wound repair in dexamethasone impaired wound healing model. Wound Repair Regen (2009) 0.87
Influence of in vitro cultivation on the integration of cell-matrix constructs after subcutaneous implantation. Tissue Eng (2007) 0.86
Fas-ligand--iron fist or Achilles' heel? Clin Immunol (2002) 0.86
Interleukin (IL)-10 inhibits RANTES-, tumour necrosis factor (TNF)- and nerve growth factor (NGF)-induced mast cell migratory response but is not a mast cell chemoattractant. Immunol Lett (2009) 0.85
Progesterone reduces the migration of mast cells toward the chemokine stromal cell-derived factor-1/CXCL12 with an accompanying decrease in CXCR4 receptors. Am J Physiol Endocrinol Metab (2007) 0.85
Lymphatic regeneration across an incisional wound: inhibition by dexamethasone and aspirin, and acceleration by a micronized purified flavonoid fraction. Eur J Pharmacol (2006) 0.80
Nanomaterial cytotoxicity is composition, size, and cell type dependent. Part Fibre Toxicol (2010) 1.75
Development of aliphatic biodegradable photoluminescent polymers. Proc Natl Acad Sci U S A (2009) 1.54
A rabbit model for capsular contracture: development and clinical implications. Plast Reconstr Surg (2006) 1.51
Surface chemistry influences implant biocompatibility. Curr Top Med Chem (2008) 1.44
Pulmonary angiogenesis in a rat model of hepatopulmonary syndrome. Gastroenterology (2008) 1.23
Surface chemistry influences cancer killing effect of TiO2 nanoparticles. Nanomedicine (2008) 1.23
Development of biodegradable crosslinked urethane-doped polyester elastomers. Biomaterials (2008) 1.21
The role of endothelin-1 and the endothelin B receptor in the pathogenesis of hepatopulmonary syndrome in the rat. Hepatology (2004) 1.21
Method to analyze three-dimensional cell distribution and infiltration in degradable scaffolds. Tissue Eng Part C Methods (2008) 1.21
Tissue responses to thermally-responsive hydrogel nanoparticles. J Biomater Sci Polym Ed (2004) 1.19
Injectable citrate-based mussel-inspired tissue bioadhesives with high wet strength for sutureless wound closure. Biomaterials (2012) 1.18
Analysis of pulmonary heme oxygenase-1 and nitric oxide synthase alterations in experimental hepatopulmonary syndrome. Gastroenterology (2003) 1.16
Synthesis and characterization of a biodegradable elastomer featuring a dual crosslinking mechanism. Soft Matter (2010) 1.15
Transplantation of mesenchymal stem cells from young donors delays aging in mice. Sci Rep (2011) 1.13
Development of a temperature-sensitive composite hydrogel for drug delivery applications. Biotechnol Prog (2006) 1.13
Synthetic aminoglycosides efficiently suppress cystic fibrosis transmembrane conductance regulator nonsense mutations and are enhanced by ivacaftor. Am J Respir Cell Mol Biol (2014) 1.10
ET-1 and TNF-alpha in HPS: analysis in prehepatic portal hypertension and biliary and nonbiliary cirrhosis in rats. Am J Physiol Gastrointest Liver Physiol (2004) 1.06
Cholangiocyte endothelin 1 and transforming growth factor beta1 production in rat experimental hepatopulmonary syndrome. Gastroenterology (2005) 1.05
Pentoxifylline attenuation of experimental hepatopulmonary syndrome. J Appl Physiol (1985) (2006) 1.05
Histamine release and fibrinogen adsorption mediate acute inflammatory responses to biomaterial implants in humans. J Transl Med (2007) 1.05
Surface chemistry influences implant-mediated host tissue responses. J Biomed Mater Res A (2008) 1.05
2-Hydroxypropyl-β-cyclodextrin promotes transcription factor EB-mediated activation of autophagy: implications for therapy. J Biol Chem (2014) 1.02
Real time monitoring of biomaterial-mediated inflammatory responses via macrophage-targeting NIR nanoprobes. Biomaterials (2011) 0.98
Prostatic stromal cells derived from benign prostatic hyperplasia specimens possess stem cell like property. Prostate (2007) 0.96
Novel polymeric scaffolds using protein microbubbles as porogen and growth factor carriers. Tissue Eng Part C Methods (2010) 0.96
Citric-acid-derived photo-cross-linked biodegradable elastomers. J Biomater Sci Polym Ed (2010) 0.96
Nanotopography: cellular responses to nanostructured materials. J Nanosci Nanotechnol (2006) 0.96
Development of intrinsically photoluminescent and photostable polylactones. Adv Mater (2014) 0.94
Scaffold Sheet Design Strategy for Soft Tissue Engineering. Nat Mater (2010) 0.92
Fibroblast/fibrocyte: surface interaction dictates tissue reactions to micropillar implants. Biomacromolecules (2011) 0.91
Dual growth factor releasing multi-functional nanofibers for wound healing. Acta Biomater (2013) 0.90
Species and density of implant surface chemistry affect the extent of foreign body reactions. Langmuir (2008) 0.90
Fluorescence imaging enabled urethane-doped citrate-based biodegradable elastomers. Biomaterials (2013) 0.90
Bioresorbable polymeric stents: current status and future promise. J Biomater Sci Polym Ed (2003) 0.89
The pivotal role of fibrocytes and mast cells in mediating fibrotic reactions to biomaterials. Biomaterials (2011) 0.89
Phagocyte responses to degradable polymers. J Biomed Mater Res A (2007) 0.89
Near-infrared light-triggered micelles for fast controlled drug release in deep tissue. Biomaterials (2013) 0.89
Computational Modeling of Phagocyte Transmigration during Biomaterial-Mediated Foreign Body Responses. Proceedings (IEEE Int Conf Bioinformatics Biomed) (2011) 0.88
Cellular and molecular responses of smooth muscle cells to surface nanotopography. J Nanosci Nanotechnol (2007) 0.88
Attenuation of experimental hepatopulmonary syndrome in endothelin B receptor-deficient rats. Am J Physiol Gastrointest Liver Physiol (2009) 0.87
Noninvasive assessment of localized inflammatory responses. Free Radic Biol Med (2011) 0.87
Development and long-term in vivo evaluation of a biodegradable urethane-doped polyester elastomer. Macromol Mater Eng (2011) 0.87
Multifunctional particles for melanoma-targeted drug delivery. Acta Biomater (2012) 0.87
Studies of the cellular uptake of hydrogel nanospheres and microspheres by phagocytes, vascular endothelial cells, and smooth muscle cells. J Biomed Mater Res A (2009) 0.85
Real-time detection of implant-associated neutrophil responses using a formyl peptide receptor-targeting NIR nanoprobe. Int J Nanomedicine (2012) 0.84
Can breast MRI predict axillary lymph node metastasis in women undergoing neoadjuvant chemotherapy. Ann Surg Oncol (2010) 0.84
A rapid and sensitive method for measuring N-acetylglucosaminidase activity in cultured cells. PLoS One (2013) 0.84
Molecular responses of vascular smooth muscle cells and phagocytes to curcumin-eluting bioresorbable stent materials. Biomaterials (2004) 0.83
A mathematical model for foreign body reactions in 2D. Int J Comput Math (2011) 0.83
A computational model of fibroblast and macrophage spatial/temporal dynamics in foreign body reactions. J Immunol Methods (2013) 0.83
The effect of erythropoietin on autologous stem cell-mediated bone regeneration. Biomaterials (2013) 0.82
A Predictive Tool for Foreign Body Fibrotic Reactions Using 2-Dimensional Computational Model. Open Access Bioinformatics (2011) 0.82
Viscoelastic behavior and in vivo release study of microgel dispersions with inverse thermoreversible gelation. Biomacromolecules (2007) 0.82
Multi-ligand poly(L-lactic-co-glycolic acid) nanoparticles inhibit activation of endothelial cells. J Cardiovasc Transl Res (2013) 0.81
Molecular responses of vascular smooth muscle cells to paclitaxel-eluting bioresorbable stent materials. J Biomed Mater Res A (2004) 0.81
Injectable biomaterials for incontinence and vesico-ureteral reflux: current status and future promise. J Biomed Mater Res B Appl Biomater (2006) 0.81
The use of chemokine-releasing tissue engineering scaffolds in a model of inflammatory response-mediated melanoma cancer metastasis. Biomaterials (2011) 0.81
Magnetic-based multi-layer microparticles for endothelial progenitor cell isolation, enrichment, and detachment. Biomaterials (2013) 0.80
Papilloma on core biopsy: excision vs. observation. Ann Surg Oncol (2014) 0.80
In vivo NIR imaging with PbS quantum dots entrapped in biodegradable micelles. J Biomed Mater Res A (2012) 0.80
Real-time noninvasive monitoring of in vivo inflammatory responses using a pH ratiometric fluorescence imaging probe. Adv Healthc Mater (2013) 0.79
A NEW CLASS OF THIN FILM HYDROGELS PRODUCED BY PLASMA POLYMERIZATION. Chem Mater (2007) 0.79
Curcumin impregnation improves the mechanical properties and reduces the inflammatory response associated with poly(L-lactic acid) fiber. J Biomater Sci Polym Ed (2005) 0.78
Role of alumina nanoporosity in acute cell response. J Nanosci Nanotechnol (2011) 0.78
Evaluation of cloned cells, animal model, and ATRA sensitivity of human testicular yolk sac tumor. J Transl Med (2012) 0.78
Low ING4 protein expression detected by paraffin-section immunohistochemistry is associated with poor prognosis in untreated patients with gastrointestinal stromal tumors. Gastric Cancer (2013) 0.78
In situ re-endothelialization via multifunctional nanoscaffolds. ACS Nano (2014) 0.78
Combined chemo- and photo-thermal therapy delivered by multifunctional theranostic gold nanorod-loaded microcapsules. Nanoscale (2015) 0.78
Humoral immunity-mediated chronic rejection in liver transplantation is associated with predominant IL-10 expression. Front Biosci (Elite Ed) (2012) 0.78
NANOTECHNOLOGY IN THE TREATMENT AND DETECTION OF INTRAOCULAR CANCERS. J Biomed Nanotechnol (2008) 0.78
Novel thermogelling dispersions of polymer nanoparticles for controlled protein release. Nanomedicine (2012) 0.77
Intraocular pressure changes: an important determinant of the biocompatibility of intravitreous implants. PLoS One (2011) 0.77
Effects of nanoporous alumina on inflammatory cell response. J Biomed Mater Res A (2013) 0.77
A hybrid computational model for phagocyte transmigration. Proc IEEE Int Symp Bioinformatics Bioeng (2008) 0.77
Effects of combined octreotide and aspirin on the growth of gastric cancer. Chin Med J (Engl) (2003) 0.77
In vivo evaluation of medical device-associated inflammation using a macrophage-specific positron emission tomography (PET) imaging probe. Bioorg Med Chem Lett (2013) 0.77
Myogenic stem cell-laden hydrogel scaffold in wound healing of the disrupted external anal sphincter. Int Urogynecol J (2015) 0.76
Enhanced intratumoral uptake of quantum dots concealed within hydrogel nanoparticles. Nanotechnology (2008) 0.76
Magnetic Nanoparticles to Enhance Cell Seeding and Distribution in Tissue Engineering Scaffolds. Proc IEEE Conf Nanotechnol (2008) 0.76
Clinical outcomes of linezolid treatment for extensively drug-resistant tuberculosis in Beijing, China: a hospital-based retrospective study. Jpn J Infect Dis (2015) 0.76
Novel Quantum Dots for Enhanced Tumor Imaging. Proc IEEE Conf Nanotechnol (2008) 0.76
Nanoparticles for Uveal Melanoma Treatment. Proc IEEE Conf Nanotechnol (2008) 0.76
Purification, tandem mass characterization, and inhibition studies of oxidosqualene-lanosterol cyclase enzyme from bovine liver. Arch Biochem Biophys (2004) 0.75
Canny edge-based deformable image registration. Phys Med Biol (2017) 0.75
Nonlinear RANSAC Optimization for Parameter Estimation with Applications to Phagocyte Transmigration. Proc Int Conf Mach Learn Appl (2011) 0.75
[Expression and purification of HPV16 E2 protein and preparation of its antiserum]. Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi (2013) 0.75
[Prethrombotic status and long-time thromboembolic events in primary hypertensive patients with or without elevated homocysteine level]. Zhonghua Xin Xue Guan Bing Za Zhi (2015) 0.75
The cysteine 703 to isoleucine or histidine mutation of the oxidosqualene-lanosterol cyclase from Saccharomyces cerevisiae generates an iridal-type triterpenoid. Biochimie (2012) 0.75